Agilent Technologies, Inc. $A is Summitry LLC’s 8th Largest Position

Summitry LLC raised its position in Agilent Technologies, Inc. (NYSE:A) by 2.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 623,468 shares of the medical research company’s stock after purchasing an additional 15,629 shares during the quarter. Agilent Technologies accounts for approximately 3.4% of Summitry LLC’s portfolio, making the stock its 8th largest position. Summitry LLC owned about 0.22% of Agilent Technologies worth $80,022,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Capital A Wealth Management LLC lifted its holdings in shares of Agilent Technologies by 10,600.0% in the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after buying an additional 212 shares during the period. Davis Capital Management acquired a new stake in shares of Agilent Technologies in the third quarter valued at about $28,000. Physician Wealth Advisors Inc. lifted its holdings in Agilent Technologies by 490.0% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after buying an additional 196 shares in the last quarter. State of Wyoming bought a new position in Agilent Technologies during the 2nd quarter worth approximately $35,000. Finally, SJS Investment Consulting Inc. raised its stake in Agilent Technologies by 2,836.4% during the third quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after acquiring an additional 312 shares during the period.

Insiders Place Their Bets

In related news, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the transaction, the vice president directly owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Padraig Mcdonnell sold 911 shares of the stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total value of $130,491.64. Following the completion of the transaction, the chief executive officer owned 32,058 shares in the company, valued at approximately $4,591,987.92. The trade was a 2.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure.

Agilent Technologies Stock Up 0.7%

Shares of NYSE A opened at $125.80 on Monday. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27. The company’s 50 day moving average price is $137.84 and its 200-day moving average price is $135.53. The company has a market capitalization of $35.58 billion, a P/E ratio of 27.53, a price-to-earnings-growth ratio of 3.65 and a beta of 1.30. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The business had revenue of $1.86 billion for the quarter, compared to analysts’ expectations of $1.83 billion. During the same quarter in the prior year, the firm posted $1.46 earnings per share. The business’s quarterly revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Equities analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is 22.32%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on A shares. Bank of America boosted their price target on Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a research note on Tuesday, November 25th. JPMorgan Chase & Co. boosted their target price on shares of Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. The Goldman Sachs Group started coverage on Agilent Technologies in a research report on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price target on the stock. Robert W. Baird increased their target price on Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 25th. Finally, HSBC initiated coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price target on the stock. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $164.50.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.